IFNG and neoplasm: Tim3 was identified as a receptor expressed on IFN‐γ‐producing CD4+ and CD8+ T cells, of which the downregulation promotes T‐cell IFN‐γ‐mediated antitumour immunity and inhibits tumour growth.